mexiletine has been researched along with Sleep Wake Disorders in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy." | 9.08 | Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. ( Lins, PE; Ljunggren, JG; Oskarsson, P, 1997) |
| "To investigate the efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy." | 5.08 | Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. ( Lins, PE; Ljunggren, JG; Oskarsson, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oskarsson, P | 1 |
| Ljunggren, JG | 1 |
| Lins, PE | 1 |
1 trial available for mexiletine and Sleep Wake Disorders
| Article | Year |
|---|---|
Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group.
Topics: Anti-Arrhythmia Agents; Blood Pressure; Diabetic Neuropathies; Dose-Response Relationship, Drug; Dou | 1997 |